Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
International Journal of Peptide Research and Therapeutics|July 21, 2009
Development of Peptidomimetics Targeting IAPsSushil K Sharma, Christopher Straub, Leigh ZawelJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 31, 2009
A histone deacetylase inhibitor LBH589 downregulates XIAP in mesothelioma cell lines which is likely responsible for increased apoptosis with TRAILJames Symanowski, Nicholas Vogelzang, Leigh Zawel, et al.Proceedings of the National Academy of Sciences of the United States of America|March 7, 2002
DEC1 is a downstream target of TGF-beta with sequence-specific transcriptional repressor activitiesLeigh Zawel, Jian Yu, Christopher J Torrance, et al.The Journal of Clinical Investigation|August 5, 2008
Resistance of human glioblastoma multiforme cells to growth factor inhibitors is overcome by blockade of inhibitor of apoptosis proteinsDavid S Ziegler, Renee D Wright, Santosh Kesari, et al.The Journal of Experimental Medicine|September 15, 2010
IAP inhibitors enhance co-stimulation to promote tumor immunityMichael Dougan, Stephanie Dougan, Joanna Slisz, et al.Neuro-Oncology|July 5, 2011
A small-molecule IAP inhibitor overcomes resistance to cytotoxic therapies in malignant gliomas in vitro and in vivoDavid S Ziegler, Joanna Keating, Santosh Kesari, et al.Blood|October 13, 2006
Targeting mitochondrial factor Smac/DIABLO as therapy for multiple myeloma (MM)Dharminder Chauhan, Paola Neri, Mugdha Velankar, et al.Molecular Cancer Therapeutics|May 24, 2013
Preclinical evaluation of the WEE1 inhibitor MK-1775 as single-agent anticancer therapyAmy D Guertin, Jing Li, Yaping Liu, et al.Molecular Cancer Therapeutics|July 11, 2007
Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cellsEllen Weisberg, Andrew L Kung, Renee D Wright, et al.Pageof 2